Ranking Profile - Cogent Biosciences Inc

Introduction

Cogent Biosciences Inc (Cogent Biosciences) formerly, Unum Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes precision therapies for genetically defined diseases. The company's pipeline product portfolio includes CGT9486 which is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis, a serious disease caused by the unchecked proliferation of mast cells. It carries out clinical trials such as Apex, Summit and Peak. Cogent Biosciences is headquartered in Cambridge, Massachusetts, the US.